Jean‐Christophe Bourdon

8.5k total citations · 1 hit paper
108 papers, 6.1k citations indexed

About

Jean‐Christophe Bourdon is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Jean‐Christophe Bourdon has authored 108 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 62 papers in Molecular Biology and 24 papers in Biotechnology. Recurrent topics in Jean‐Christophe Bourdon's work include Cancer-related Molecular Pathways (76 papers), Cancer Research and Treatments (24 papers) and RNA modifications and cancer (24 papers). Jean‐Christophe Bourdon is often cited by papers focused on Cancer-related Molecular Pathways (76 papers), Cancer Research and Treatments (24 papers) and RNA modifications and cancer (24 papers). Jean‐Christophe Bourdon collaborates with scholars based in United Kingdom, France and United States. Jean‐Christophe Bourdon's co-authors include David P. Lane, Marie P. Khoury, Mark K. Saville, Dimitris P. Xirodimas, Kenneth Fernandes, Alexandra Diot, Sylvanie Surget, Ronald T. Hay, Geng Liu and Virginie Marcel and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Jean‐Christophe Bourdon

106 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53 isoforms can regulate p53 transcriptional activity

2005 631 citations Jean‐Christophe Bourdon, Kenneth Fernandes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jean‐Christophe Bourdon United Kingdom	42	4.5k	3.4k	1.2k	767	490	108	6.1k
Takashi Tokino Japan	10	6.0k 1.3×	5.4k 1.6×	1.3k 1.1×	1.2k 1.5×	694 1.4×	14	8.1k
Lee Ann Remington United States	13	3.5k 0.8×	3.5k 1.0×	981 0.8×	800 1.0×	483 1.0×	15	5.8k
Matthias Dobbelstein Germany	44	4.7k 1.0×	2.7k 0.8×	1.3k 1.0×	682 0.9×	404 0.8×	129	6.1k
Silvia Soddu Italy	44	3.8k 0.8×	2.6k 0.8×	887 0.7×	402 0.5×	679 1.4×	140	5.5k
Tomoo Iwakuma United States	32	3.7k 0.8×	2.6k 0.8×	1.3k 1.1×	476 0.6×	341 0.7×	86	5.3k
Margaret Ashcroft United Kingdom	34	3.2k 0.7×	1.7k 0.5×	1.7k 1.5×	389 0.5×	318 0.6×	58	4.6k
Edward A. Ratovitski United States	37	2.9k 0.6×	1.6k 0.5×	806 0.7×	437 0.6×	328 0.7×	75	4.2k
Ramón Mangues Spain	40	3.8k 0.8×	2.5k 0.7×	1.0k 0.8×	600 0.8×	314 0.6×	148	6.5k
Tsukasa Shibue United States	20	4.6k 1.0×	3.6k 1.1×	1.7k 1.4×	378 0.5×	824 1.7×	28	7.2k
Ada Sacchi Italy	55	5.8k 1.3×	3.7k 1.1×	1.5k 1.2×	868 1.1×	1.2k 2.5×	162	8.4k

Countries citing papers authored by Jean‐Christophe Bourdon

Since Specialization

Citations

This map shows the geographic impact of Jean‐Christophe Bourdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Christophe Bourdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Christophe Bourdon more than expected).

Fields of papers citing papers by Jean‐Christophe Bourdon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Christophe Bourdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Christophe Bourdon. The network helps show where Jean‐Christophe Bourdon may publish in the future.

Co-authorship network of co-authors of Jean‐Christophe Bourdon

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Christophe Bourdon. A scholar is included among the top collaborators of Jean‐Christophe Bourdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Christophe Bourdon. Jean‐Christophe Bourdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruano, Dina, Sebastien M. Joruiz, Mar Rodríguez‐Girondo, et al.. (2024). Germline variant affecting p53β isoforms predisposes to familial cancer. Nature Communications. 15(1). 8208–8208. 1 indexed citations

Reinhardt, Luiza Steffens, et al.. (2023). It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort. Cancer Cell International. 23(1). 228–228. 4 indexed citations

Robertson, Claire, et al.. (2022). Δ133p53 coordinates ECM-driven morphogenesis and gene expression in three-dimensional mammary epithelial acini. Journal of Cell Science. 135(21). 5 indexed citations

Bourdon, Jean‐Christophe, et al.. (2021). p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway. Cell Death and Disease. 12(10). 941–941. 12 indexed citations

Ревин, В. В., et al.. (2018). The effect of experimental hyperoxia on erythrocytes’ oxygen-transport function. Biotechnology & Biotechnological Equipment. 32(5). 1236–1250. 4 indexed citations

Joruiz, Sebastien M. & Jean‐Christophe Bourdon. (2016). p53 Isoforms: Key Regulators of the Cell Fate Decision. Cold Spring Harbor Perspectives in Medicine. 6(8). a026039–a026039. 135 indexed citations

Terrier, Olivier, Jean‐Christophe Bourdon, & Manuel Rosa‐Calatrava. (2013). p53 Protein Isoforms: Key Regulators in the Front Line of Pathogen Infections?. PLoS Pathogens. 9(4). e1003246–e1003246. 11 indexed citations

Wergeland, Line, André Sulen, Vibeke Andresen, et al.. (2013). Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53null Cell Lines. PLoS ONE. 8(2). e56276–e56276. 26 indexed citations

Camus, Suzanne, Sergio Ménendez, Kenneth Fernandes, et al.. (2012). The p53 isoforms are differentially modified by Mdm2. Cell Cycle. 11(8). 1646–1655. 31 indexed citations

10.

Ma, Dandan, Pierre Dourlen, Gilles Chatelain, et al.. (2012). Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation. Cell Death and Differentiation. 20(1). 108–116. 42 indexed citations

11.

Allende-Vega, Nerea, et al.. (2012). p53 is activated in response to disruption of the pre-mRNA splicing machinery. Oncogene. 32(1). 1–14. 80 indexed citations

12.

Terrier, Olivier, Laurence Josset, Julien Textoris, et al.. (2011). Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathway. Virology Journal. 8(1). 285–285. 37 indexed citations

13.

Ånensen, Nina, Werner Van Belle, Ingvild Haaland, et al.. (2011). Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene. 31(12). 1533–1545. 51 indexed citations

14.

Fujita, Kaori, Izumi Horikawa, Abdul M. Mondal, et al.. (2010). Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence. Nature Cell Biology. 12(12). 1205–1212. 84 indexed citations

15.

Lane, David P., et al.. (2006). p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death and Differentiation. 13(6). 962–972. 401 indexed citations

16.

Xirodimas, Dimitris P., Mark K. Saville, Jean‐Christophe Bourdon, Ronald T. Hay, & David P. Lane. (2004). Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity. Cell. 118(1). 83–97. 442 indexed citations

17.

Paitel, Erwan, Claire Sunyach, Cristine Alvès da Costa, et al.. (2003). Primary Cultured Neurons Devoid of Cellular Prion Display Lower Responsiveness to Staurosporine through the Control of p53 at Both Transcriptional and Post-transcriptional Levels. Journal of Biological Chemistry. 279(1). 612–618. 56 indexed citations

18.

Watanabe‐Fukunaga, Rie, Jean‐Christophe Bourdon, Shigekazu Nagata, et al.. (2000). Human and Mouse Fas (APO-1/CD95) Death Receptor Genes Each Contain a p53-responsive Element That Is Activated by p53 Mutants Unable to Induce Apoptosis. Journal of Biological Chemistry. 275(6). 3867–3872. 103 indexed citations

19.

Bourdon, Jean‐Christophe, et al.. (1997). Further characterisation of the p53 responsive element – identification of new candidate genes for trans-activation by p53. Oncogene. 14(1). 85–94. 134 indexed citations

20.

Bourdon, Jean‐Christophe. (1980). Growth and properties of metal clusters : applications to catalysis and the photographic process : proceedings of the 32nd international meeting of the Societe de chimie physique, Villeurbanne, 24-28 September 1979. Elsevier eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact